Infectious disease diagnosis is referred to as a laboratory test, which is implemented with the help of skilled technicians and physicians to diagnose infectious diseases. It is a diagnostic process in which the effected organism of an infectious disease is featured and identified. The sample of urine, mucus, blood, or other body fluids are analyzed to offer information about the causative organism by the use of several diagnosis procedure and instruments. Growth of the global infectious disease diagnostic market is significantly driven by rise in prevalence of infectious disease such as hepatitis, COVID-19, influenza & human immuno deficiency virus (HIV); surge in demand for point-of-care diagnostic test; rise in funding from private and government organizations for diagnostic service centers; and advancements in technologies in the domain of infectious disease diagnostics. As per the Centers for Disease Control and Prevention (CDC), in 2018, it was reported that about 1.7 million infections and 99,000 related deaths happen every year in American hospitals. Additionally, rise in demand for point-of-care testing is projected to boost the growth of the infection disease diagnostic market. In addition to this, the increase in elderly population compels the infectious disease diagnostic market growth, due to the fact that elderly individuals are more prone to infectious diseases. As per the U.S. Food and Drug Administration (FDA), in 2020, it was reported that almost 300,000 individuals aged 50 and above are diagnosed with pneumococcal pneumonia, every year. In addition, the rise in number of medical laboratories, for infectious disease diagnostic testing is anticipated to the growth of the infection disease diagnostic market. Moreover, the molecular diagnostics has been performed in centralized laboratories since several years; however, the few drawbacks of centralized laboratories are delay in results, high cost of tests, less precision and late disease diagnosis have resulted in continuous shift in decentralizing clinical laboratory testing for infectious disease diagnosis which is also likely to propel the infection disease diagnostic market growth. On the other hand, the unfavorable reimbursement scenario is projected to hinder the market.

Furthermore, the developing nations such as India, Brazil, South Korea, and Mexico are projected to provide lucrative growth opportunities for key players operating in the infectious disease diagnostics market. This can be ascribed to the high disease incidence, huge patient population, developing healthcare infrastructure, rising disposable income, and increasing medical tourism in these countries. In addition to the factors mentioned above, the Asia Pacific has appeared to be an adaptive and business-friendly hub owing to relatively less stringent regulations and data requirements.

The global Infectious Disease Diagnostics Market is segregated on the basis of Product and Service as Instruments, Assays, Reagents, and Kits and Software and Services. Based on Disease Type the global Infectious Disease Diagnostics Market is segmented in Hepatitis, Influenza, Tuberculosis, Human Immunodeficiency Virus and Others.

The global Infectious Disease Diagnostics Market report provides geographic analysis covering regions, such as Europe, North America, Asia Pacific, and Rest of The World. The Infectious Disease Diagnostics Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Analysis

F. Hoffmann-La Roche Ltd, Abbott Diagnostics, bioMérieux SA, Becton-Dickinson & Company, Siemens Healthineers and others are among the major players in the global Infectious Disease Diagnostics Market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

• In March 2020, Abbott, a global healthcare company, declared the launch of Abbott ID NOW COVID-19 test, which is a molecular point-of-care test used to identify COVID-19 in as less as 5 minutes.
• In May 2021, Neuberg Diagnostic, a leading company which provides best-in-class laboratories, introduced the clinical laboratory's operation in the U.S. to provide genomic and molecular testing on new generation sequencing technology.
• In June 2018, F. Hoffmann-La Roche Ltd. made a strategic partnership with GE Healthcare to together develop and co-market digital clinical decision support solutions.

The global Infectious Disease Diagnostics Market has been segmented as below:

Infectious Disease Diagnostics Market, By Product and Service

• Instruments
• Assays, Reagents, and Kits
• Software and Services

Infectious Disease Diagnostics Market, By Disease Type

• Hepatitis
• Influenza
• Tuberculosis
• Human Immunodeficiency Virus
• Others

Infectious Disease Diagnostics Market, By Region

• Europe
• North America
• Asia Pacific
• Rest of The World

Infectious Disease Diagnostics Market, By Company

• F. Hoffmann-La Roche Ltd
• Abbott Diagnostics
• bioMérieux SA
• Becton-Dickinson & Company
• Siemens Healthineers
• Thermo Fischer Scientific, Inc.
• Bio-Rad Laboratories
• Sysmex Corporation
• Beckman Coulter
• Danaher Corporation
• Alere Inc.
• Chembio Diagnostics Inc.
• Cepheid Inc
• DiaSorin
• Meridian Bioscience
• Trinity Biotech
• Sekisui Diagnostics
• Quidel Corporation
• MedMira, Inc.
• Calypte Biomedical Corporation

The report covers the below scope:

• Global Infectious Disease Diagnostics Market sizes from 2020 to 2026, along with CAGR for 2020-2026
• Market size comparison for 2019 vs 2026, with actual data for 2019, estimates for 2019 and forecast from 2020 to 2026
• Global Infectious Disease Diagnostics Market trends, covering comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Infectious Disease Diagnostics Market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
• Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

• Base year - 2019
• Estimated year - 2019
• Projected year - 2020
• Forecast period - 2021 to 2026

Report Scope:

The global Infectious Disease Diagnostics Market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Infectious Disease Diagnostics Market share. Major industry players with significant revenue share include F. Hoffmann-La Roche Ltd, Abbott Diagnostics, bioMérieux SA, Becton-Dickinson & Company, Siemens Healthineers and others.

Why to Buy this Report:

• Gain detailed insights on the Infectious Disease Diagnostics industry trends
• Find complete analysis on the market status
• Identify the Infectious Disease Diagnostics Market opportunities and growth segments
• Analyse competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

• The report targeted towards the existing players in the industry is as follows:
• Market Manufacturers/Service Providers
• Market Wholesale/Traders
• Investment and Financial Institutions

Free and Paid Customization based on the requirement